Figure 2.

Bronchodilatador response in Cystic Fibrosis patients modulated by polymorphism in ADRB2 gene. Response to the inhaler bronchodilators by the alteration of spirometry markers values in the Cystic Fibrosis patients according to polymorphism Arg16Gly in ADRB2 gene. A. Bloxplot of the variation in the FEV₁(%) before and after using bronchodilators in patients without without taking CFTR mutation into account. # p:0.361; * p:0.001; ¥ p:0.002. B. Bloxplot with the variation in the FEF25-75(%) before and after using bronchodilators in patients without without taking CFTR mutation into account. # p:0.031; * p:0.026; ¥ p:0.01. Analysis made group by group by the T´student test. The data from the pulmonary function test are in percentage of the predicted population value.